Blocking the sEH enzyme alleviated pain [26,27], restored renal function [21,22,43], and maintained cardiac myocyte morphology and calcium cycling [54] in mouse models of diabetic neuropathy, nephropathy, and cardiomyopathy, respectively. This evidence concerns the gene EPHX2 and kidney disorder.